Fractional Flow Reserve Market to amass USD 970 Mn by 2024

September 27, 2019

According to the new research report available at under the title ‘Fractional Flow Reserve Market Growth 2019-2024’, the worldwide fractional flow reserve (FFR) market is anticipated to exceed US $970 million by the year 2024.

Fractional flow reserve is a method which is utilized in coronary catheterization to measure the pressure difference across a coronary artery stenosis. It provides information about the possibility of stenosis obstructing oxygen supply to heart muscle.

Fractional flow reserve is a novel and potent clinically useful math-based solution for the determination of stenotic coronary artery atherosclerosis. Collaborative/reliability measurement between laboratories is an important metric that appears to be muddled in a proprietary contest to claim cardiac mathematics.

According to the report, fractional flow reserve market was worth US $530 million in 2019 and is anticipated to grow with a CAGR of 10.7% by the year 2024. Furthermore, competition in the market is intense, big players hold most of the important technologies and patents.

Fractional flow reserve market is analyzed on the basis of type, application spectrum and regional landscape. Based on the type, the market is segmented as single vessel disease and multi vessel disease, wherein multi vessel disease dominated the market with 63% proportion in 2017. While considering the application spectrum, the market is fragmented as coronary artery disease and cardiology.

Request sample copy of this Report

Speaking of the regional landscape, the market is divided into four major region; China, India, Australia, Japan, Southeast Asia, and Korea fall under Asia Pacific; Europe consists of Germany, UK, France, Italy, Spain, and Russia; Americas comprises of Brazil, the U.S., Mexico, and Canada; and Egypt, Turkey, GCC Countries, South Africa, and Israel come under Middle East & Africa. However, North America led the worldwide FFR market with 47% consumption share in 2017.

The prominent companies operating in fractional flow reserve market include Opsens, Bracco, Boston Scientific, Abbott, and Philips among others.